Treatment of ringworm infections of skin with terbinafine

Phase 3

Active, not recruiting

• Conditions: Tinea corporis, tinea cruris, tinea manuum, tinea pedis

• Registration Number: CTRI/2017/05/008687
• Lead Sponsor: Institute of Medical Sciences Banaras Hindu University

Brief Summary

There is a general impression among dermatologists in India that patients with tinea infections are not responding to treatment with terbinafine, which used to be a very effective drug. However, clinical data in this regard is not available. This study aims to look into the effectiveness of terbinafine in real-world situation.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01-02
• Last Update Posted: 2017-05-04

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Patients with tinea corporis, tinea cruris, tinea manuum and tinea pedis who show fungal elements on KOH microscopy of skin scrapings.

Exclusion Criteria

• Use of terbinafine (oral or topical) in past 1 week 2.
• Pregnancy or lactation 3.
• Past history of drug reaction to terbinafine (oral or topical) 4.
• Inability of the patient to come for follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complete clearance of lesions and negative KOH microscopy	0, 2, 4 weeks. | Cured patients reviewed after 1 month of completion of treatment and assessed for reappearance of leions

Trial Locations

Locations (1)

SS Hospital; 🇮🇳 Varanasi, UTTAR PRADESH, India

SS Hospital

🇮🇳Varanasi, UTTAR PRADESH, India

Sanjay Singh

Principal investigator

05422309488

sanjaye2@gmail.com